Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoembolization kills tumor cells by blocking the blood flow to the tumor and
keeping chemotherapy drugs near the tumor.
PURPOSE: Phase II trial to study the effectiveness of chemoembolization in treating patients
who have primary liver cancer or metastases to the liver that cannot be surgically removed.